8-K 1 a27834e8vk.htm FORM 8-K e8vk
Table of Contents

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
February 22, 2007
ENDOLOGIX, INC.
(Exact name of registrant as specified in its charter)
         
Delaware
(State or other jurisdiction
of incorporation) 		  000-28440
(Commission File Number) 		  68-0328265
(I.R.S. Employer
Identification No.)
         
11 Studebaker, Irvine, CA
(Address of principal executive offices) 		      92618
(Zip Code)
Registrant’s telephone number, including area code: (949) 595-7200
Not applicable
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
     
¨
  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
    
¨
  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
    
¨
  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
    
¨
  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 

TABLE OF CONTENTS

Item 2.02 Results of Operations and Financial Condition.
Item 9.01 Financial Statements and Exhibits.
SIGNATURES
EXHIBIT INDEX
EXHIBIR 99.1
EXHIBIT 99.2

Table of Contents

Item 2.02 Results of Operations and Financial Condition.
     On February 22, 2007, Endologix, Inc. issued a press release to report its financial results for the quarter and year ended December 31, 2006. The press release is furnished as Exhibit 99.1 and is incorporated herein by reference.
     On February 22, 2007, Endologix, Inc. held a conference call with analysts and investors, the transcript of which is furnished as Exhibit 99.2 and is incorporated herein by reference.
     The information in this Current Report on Form 8-K, including Exhibit 99.1 and 99.2, is furnished pursuant to Item 2.02 and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits.
(c)   Exhibits
     
Exhibit Number   Description
99.1
  Press Release dated February 22, 2007.
99.2
  Transcript of Conference Call held on February 22, 2007.

 

Table of Contents

SIGNATURES
     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
  ENDOLOGIX, INC.
 		  
February 27, 2007  /s/ Robert J. Krist    
  Robert J. Krist   
  Chief Financial Officer   

 

Table of Contents

         
EXHIBIT INDEX
     
Exhibit    
Number   Description
99.1
  Press Release dated February 22, 2007.
99.2
  Transcript of Conference Call held on February 22, 2007.